CompaniesPyramid Labs

Pyramid Labs

defunct
About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (5)
View all

Total Trials

5

As Lead Sponsor

5

As Collaborator

0

Total Enrollment

2,299

By Status

RECRUITING: 1UNKNOWN: 1ENROLLING_BY_INVITATION: 1ACTIVE_NOT_RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
Today
NCT04974567
NCT04928014
NCT05223218
NCT05268224
Hover over trial bars to see details

Recent Trials

NCT05268224Lead Sponsor
A Tear-based, Lab-developed Test for Breast Cancer for Women With Dense Breast Tissue
N/ARecruiting
1,500 participants
Started: Oct 1, 2021 · Completed: Oct 31, 2024
NCT05223218Lead Sponsor
Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study
N/AUnknown
500 participants
Started: Aug 25, 2021 · Completed: Dec 31, 2023
NCT04928014Lead Sponsor
Validation of a Tear-based Screening Assay for Breast Cancer
N/AEnrolling by invitation
205 participants
Started: Jun 1, 2021 · Completed: Dec 31, 2025
NCT04974567Lead Sponsor
Tear Based Sample Collection Breast Cancer Detection
N/AActive, not recruiting
50 participants
Started: Apr 28, 2021 · Completed: Sep 15, 2025
NCT04542980Lead Sponsor
Qualitative Evaluation of Tear Fluid and Blood for Auto Antibodies Produced in Response to COVID-19
N/ACompleted
44 participants
Started: Sep 15, 2020 · Completed: Dec 31, 2020